P-84 HAVE CFTR MODULATORS CHANGED THE NEED FOR LIVER TRANSPLANTATION AMONG PATIENTS WITH CYSTIC FIBROSIS? AN ANALYSIS OF THE UNOS DATABASE

P-84 HAVE CFTR MODULATORS CHANGED THE NEED FOR LIVER TRANSPLANTATION AMONG PATIENTS WITH CYSTIC FIBROSIS? AN ANALYSIS OF THE UNOS DATABASE

Conflict of interest: No Introduction and Objectives: The impact of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators on the natural history of liver disease is unknown. The objective of this study is to assess changes in the rates of liver transplantation compared to lung t...

Full description

Saved in:

Bibliographic Details
Main Authors:	MANUEL MENDIZABAL, Claire Cywes, Nicolas Muñoz, Amay Banker, Christian Bermudez, Denis Hadjiliadis, Peter Abt
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124004812
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in the treatment of cystic fibrosis: CFTR modulators
by: Maria Dolores Pastor-Vivero, et al.
Published: (2025-05-01)

Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
by: V. Witko-Sarsat, et al.
Published: (1999-01-01)

A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01)

Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators
by: Burkhard Tümmler, et al.
Published: (2025-05-01)

Improvement of intestinal inflammation after treatment with CFTR modulators in cystic fibrosis patients
by: Ruth García Romero, et al.
Published: (2025-05-01)

Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis
by: Jaime L. Rubin, et al.
Published: (2025-07-01)

Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator Therapies
by: Guillermo García-Pérez-de-Sevilla, et al.
Published: (2025-07-01)

The effect of triple CFTR modulator therapy and azithromycin on ion channels and inflammation in cystic fibrosis
by: Suhad Bani Melhim, et al.
Published: (2024-12-01)

Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes
by: Marie Yskout, et al.
Published: (2023-01-01)

CFTR ion transport deficiency primes the epithelium for partial epithelial-mesenchymal transition in cystic fibrosis
by: Cláudia S. Rodrigues, et al.
Published: (2025-08-01)

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
by: Paulami Chatterjee, et al.
Published: (2024-09-01)

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators
by: Georgia Mitropoulou, MD, et al.
Published: (2024-11-01)

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
by: Karin Yaacoby-Bianu, et al.
Published: (2025-01-01)

Clinical Outcomes in Patients with Cystic Fibrosis Receiving CFTR Modulators: A Comparison of Childhood Versus Adolescent Initiation
by: Eman A. Toraih, et al.
Published: (2025-01-01)

Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy
by: Justyna Milczewska, et al.
Published: (2024-12-01)

Relationship Between Added Sugar Intake and Metabolic Outcomes in Adults With Cystic Fibrosis Using CFTR Modulator Therapy
by: Swati S Zaveri, et al.
Published: (2025-05-01)

Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators
by: Owen W. Tomlinson, et al.
Published: (2024-09-01)

Effect of CFTR modulators on glucose homeostasis in children and young adults with cystic fibrosis-related diabetes: a systematic review
by: Paola Giordano, et al.
Published: (2025-08-01)

Evaluation of the Effectiveness of Using the CFTR Modulator Ivacaftor/Lumacaftor in Children with Cystic Fibrosis in the Sverdlovsk Region (Prospective Cohort Study)
by: Yuliya O. Vasenyova, et al.
Published: (2024-09-01)

In-depth analysis of cystic fibrosis cases caused by CFTR gene variation and research on the prediction and simulation of the impact on protein function
by: Yuxia Shan, et al.
Published: (2025-05-01)

Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI)
by: Tomke Sütering, et al.
Published: (2024-12-01)

A severe early presentation of cystic fibrosis in an infant with a homozygous c.1375_1383del CFTR variant- a case report
by: Abdullah Yousef, et al.
Published: (2025-08-01)

Establishment and characterization of an induced pluripotent stem cell line from a Japanese cystic fibrosis patient with homozygous 1540del10 CFTR mutation
by: Hitoshi Okumura, et al.
Published: (2025-09-01)

AKR1D1 and CFTR homozygous variants in an infant with combined bile acid synthesis defect and cystic fibrosis: first case report and management plan
by: Nehal M. Elkoofy, et al.
Published: (2025-08-01)

The impact of donor liver fibrosis on the outcomes of patients who undergo liver transplant: a cohort study from UNOS database
by: Congwen Bian, et al.
Published: (2025-04-01)

Cystic Fibrosis in Asia
by: Shakil Ahmed, et al.
Published: (2020-01-01)

Aspirin and Some Other Nonsteroidal Anti-Inflammatory Drugs Inhibit Cystic Fibrosis Transmembrane Conductance Regulator Protein Gene Expression in T-84 Cells
by: Danielle Tondelier, et al.
Published: (1999-01-01)

Lived experiences for individuals with cystic fibrosis who have undergone lung transplantation: a qualitative study
by: Ulrika Skogeland, et al.
Published: (2025-02-01)

Avances en el tratamiento de la fibrosis quística: los moduladores de la CFTR
by: Maria Dolores Pastor-Vivero, et al.
Published: (2025-05-01)

Intact spermatogenesis in an azoospermic patient with AZFa (sY84 and sY86) microdeletion and a homozygous TG12-5T variant in CFTR
by: Yifan Sun, et al.
Published: (2025-04-01)

Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects
by: Ana Lúcia Da Silva Cunha, et al.
Published: (2024-12-01)

Pancreatic, nutritional and clinical outcomes in children 0–5 years with cystic fibrosis during the first 2 years of CFTR modulator therapy (PaNC): a multicentre prospective observational study protocol
by: Tamarah Katz, et al.
Published: (2025-07-01)

New Treatment of Cystic Fibrosis
by: article Editorial
Published: (2020-01-01)

Burden of cystic fibrosis in children
by: Kathryn Bresnick, et al.
Published: (2021-01-01)

Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Jane E. Gross, et al.
Published: (2025-03-01)

Effect of cystic fibrosis transmembrane conductance regulator modulators and dedicated cystic fibrosis gastrointestinal clinic visits on the incidence of distal intestinal obstructive syndrome in persons with cystic fibrosis.
by: Nicha Wongjarupong, et al.
Published: (2025-01-01)

Effect of cystic fibrosis transmembrane conductance regulator modulators and dedicated cystic fibrosis gastrointestinal clinic visits on the incidence of distal intestinal obstructive syndrome in persons with cystic fibrosis
by: Nicha Wongjarupong, et al.
Published: (2025-01-01)

Mental disorders in patients with cystic fibrosis
by: A. A. Klimenko, et al.
Published: (2025-01-01)

Vitamin D Deficiency in Cystic Fibrosis
by: William B. Hall, et al.
Published: (2010-01-01)

Hypercalciuria and nephrocalcinosis in cystic fibrosis patients
by: Uğur Ozçelik, et al.
Published: (2004-01-01)